Metraipolis › archive › dc_8006344ae40d

Adropin as a Marker in Type 2 Diabetes: Insights Into Diabetic Kidney Disease and Chronic Heart Failure — Europe PMC PMID:41054696

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41054696
DOI
10.7759/cureus.91572
License (as archived)
solo-consultazione
Archived
2026-11-10T03:56:37.192Z
SHA-256 of the archived text
e674ca1d1376e175e7b25d681d0d8665994246ba445008728e6ccac877460d78
Stable URL of this page
https://metraipolis.com/documento/dc_8006344ae40d

How to cite

Adropin as a Marker in Type 2 Diabetes: Insights Into Diabetic Kidney Disease and Chronic Heart Failure — Europe PMC PMID:41054696 — Europe PMC (en), https://europepmc.org/article/MED/41054696 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8006344ae40d (Metraipolis archive dc_8006344ae40d, sha256 e674ca1d1376e175e7b25d681d0d8665994246ba445008728e6ccac877460d78)
BibTeX
@misc{dc8006344ae40d,
  title = {Adropin as a Marker in Type 2 Diabetes: Insights Into Diabetic Kidney Disease and Chronic Heart Failure — Europe PMC PMID:41054696},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41054696},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8006344ae40d; sha256 e674ca1d1376e175e7b25d681d0d8665994246ba445008728e6ccac877460d78},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41054696. Agents can read the archived copy with the MCP tool read_document.